期刊文献+

创面感染多重耐药菌的分布及感染因素研究 被引量:9

Study on multidrug resistance organism distribution and risk factors of wound infection
原文传递
导出
摘要 目的了解创面感染多重耐药菌(MDRO)的分布及感染危险因素,为制定防控措施提供依据。方法通过临床观察和细菌分离鉴定技术,对上海市某医院住院患者创面标本进行检测与结果分析。结果调查期间从住院患者创面分泌物标本中分离出病原菌315株,含多重耐药菌217株,占68.89%。居前5位的MDRO分别有金黄色葡萄球菌、铜绿假单胞菌、大肠埃希菌、肺炎克雷伯杆菌和鲍曼不动杆菌。创面MDRO患者危险因素为有住院史、创面面积大、难愈性创面、近期使用抗菌药物和近期手术治疗者。结论创面感染病原菌中,多重耐药菌比例高,金黄色葡萄球菌为绝对优势菌。 Objective To investigate the wound multidrug resistance organism( MDRO) distribution and risk factors for wound MDRO infection,so as to provide reference to prevent and control of wound MDRO infection. Methods Clinical observation,bacteria separation and identification technology were used to detect and analysis the wound specimens of hospitalized patients in a hospital. Results 315 strains of pathogenic bacterial isolated from wound during the investigation period and 217 strains( 68. 89%) belong to MDRO. The top five MDRO were Staphylococcus aureus,Pseudomonas aeruginosa,Escherichia coli,Klebsiella pneumoniae and Acinetobacter baumannii. Risk factors for wound MDRO patients were the history of hospitalization,large wound area,refractory wound,recent antibacterial drugs used and recent operation. Conclusion High proportion of MDRO existing on wound. Staphylococcus aureus are predominance bacterium absolutely.
出处 《中国消毒学杂志》 CAS 北大核心 2017年第2期148-149,152,共3页 Chinese Journal of Disinfection
关键词 创面感染 病原菌 多重耐药菌 监测 wound infection bacterial multidrug resistance organism surveillance
  • 相关文献

参考文献7

二级参考文献42

  • 1XIONG Zi-zhong ZHU De-mei WANG Fu ZHANG Ying-yuan.CTX-M-14, CTX-M-24 and resistance in Escherichia coli and Klebsiella pneumoniae clinical isolates[J].Chinese Medical Journal,2006(2):160-164. 被引量:13
  • 2祁少海,刘坡,利天增,谢举临,徐盈斌,张涛,陈晓东,赵李平.慢性难愈合创面细菌耐药性分析[J].中国微生态学杂志,2006,18(2):117-119. 被引量:6
  • 3任南,文细毛,吴安华.全国医院感染横断面调查结果的变化趋势研究[J].中国感染控制杂志,2007,6(1):16-18. 被引量:352
  • 4赵彩芸,肖永红,王珊,李耘,刘健,杨维维,郝凤兰.临床分离耐甲氧西林金黄色葡萄球菌染色体mec盒基因的分型[J].中华传染病杂志,2007,25(10):611-616. 被引量:23
  • 5Siegel J D,Rhinehart E,Jackson M,et al.Management of multidrugresistant organisms in health care settings, 2006[J].Am J Infect Control,2007,35(10 Suppl 2):S165-S193.
  • 6Magiorakos A P,Srinivasan A,Carey R B, et al.Multidrugresistant, extensively drugresistant and pandrugresistant bacteria:an international expert proposal for interim standard definitions for acquired resistance[J].Clin Microbiol Infect,2012,18(3):268-281.
  • 7CLSI. Performance standards for antimicrobial susceptibility testing. 16th informational supplement.CLSI document[J].Wayne,Pennsylvania,2006,27(1):1-182.
  • 8RodriguezBano J, Navarro M D, Romero L, et al. Clinical and molecular epidemiology of extendedspectrum betalactamaseproducing Escherichia coli as a cause of nosocomial infection or colonization:implications for control[J].Clin Infect Dis,2006,42(1):37-45.
  • 9Surasarang K,Narksawat K,Danchaivijitr S,et al.Risk factors for multidrug resistant Acinetobacter baumannii nosocomial infection[J].J Med Assoc Thai,2007,90(8):1633-1639.
  • 10Aloush V,NavonVenezia S,SeigmanIgra Y, et al.Multidrugresistant Pseudomonas aeruginosa:risk factors and clinical impact[J].Antimicrob Agents Chemother,2006,50(1):43-48.

共引文献1450

同被引文献78

引证文献9

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部